Deep Dive into FDA’s Expedited Programs for Drug Development
If you are developing products for serious and life-threatening illnesses with unmet medical needs, there are several mechanisms offered by FDA that can accelerate your product development and the review of your BLA/NDA. This webinar will provide you some background on each of the tools and how you can leverage them to your advantage.
The tools include – Fast Track (FTD), Breakthrough Therapy Designation (BTD), Regenerative Medicine and Advanced Therapies (RMAT), accelerated approval and priority review.
Some key learning points:
Understand various mechanisms created by FDA to speed the product development and the BLA/NDA review
Comprehend the types of situation to which these tools are applicable
Familiar with the differences in the requirements to obtain each tool
Download the full presentation now
Fill in the form to download the content
Thank you !
Your file is ready to download.
You will receive by email a download link in a few minutes.
Sample of the presentation
Charlene Revel, PharmD, MSc.
Senior Regulatory Scientist, Drugs and Biologics
Charlene has great experience in the implementation of global regulatory and scientific strategies as well as submissions for the development and marketing of biologics products, drugs and medical devices.
Michael Day, PhD
Senior Director of Regulatory Science
As Senior Director Regulatory Science at VCLS, Michael (Mike) is responsible for providing both regulatory strategy and CMC consulting services…
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this site, you will need to enable or disable cookies again.
Third party cookies
This site uses Google Analytics to collect anonymous information such as the number of visitors to the site and the most popular pages.
Keeping this cookie activated helps us to improve our website.
Please first enable strictly necessary cookies so that we can save your preferences !